当前位置: 首页 >> 检索结果
共有 3920 条符合本次的查询结果, 用时 5.5844667 秒

1681. Immunodeficiency diseases caused by defects in phagocytes.

作者: J A Lekstrom-Himes.;J I Gallin.
来源: N Engl J Med. 2000年343卷23期1703-14页

1682. Screening for lung cancer.

作者: E F Patz.;P C Goodman.;G Bepler.
来源: N Engl J Med. 2000年343卷22期1627-33页

1683. Roads leading to breast cancer.

作者: D Haber.
来源: N Engl J Med. 2000年343卷21期1566-8页

1684. Renal transplantation in black Americans.

作者: C J Young.;R S Gaston.
来源: N Engl J Med. 2000年343卷21期1545-52页

1685. Cytokines in alcoholic and nonalcoholic steatohepatitis.

作者: H Tilg.;A M Diehl.
来源: N Engl J Med. 2000年343卷20期1467-76页

1686. Antibodies and resistance to natural HIV infection.

作者: G J Nabel.;N J Sullivan.
来源: N Engl J Med. 2000年343卷17期1263-5页

1687. Graves' disease.

作者: A P Weetman.
来源: N Engl J Med. 2000年343卷17期1236-48页

1688. Myocarditis.

作者: A M Feldman.;D McNamara.
来源: N Engl J Med. 2000年343卷19期1388-98页

1689. Nonsurgical treatment of ectopic pregnancy.

作者: G H Lipscomb.;T G Stovall.;F W Ling.
来源: N Engl J Med. 2000年343卷18期1325-9页

1690. Primary immunodeficiency diseases due to defects in lymphocytes.

作者: R H Buckley.
来源: N Engl J Med. 2000年343卷18期1313-24页

1691. Genetic defects of intracellular-membrane transport.

作者: V M Olkkonen.;E Ikonen.
来源: N Engl J Med. 2000年343卷15期1095-104页

1692. Primary care for survivors of breast cancer.

作者: H J Burstein.;E P Winer.
来源: N Engl J Med. 2000年343卷15期1086-94页

1693. T-cell function and migration. Two sides of the same coin.

作者: U H von Andrian.;C R Mackay.
来源: N Engl J Med. 2000年343卷14期1020-34页

1694. Multiple sclerosis.

作者: J H Noseworthy.;C Lucchinetti.;M Rodriguez.;B G Weinshenker.
来源: N Engl J Med. 2000年343卷13期938-52页

1695. Thromboangiitis obliterans (Buerger's disease).

作者: J W Olin.
来源: N Engl J Med. 2000年343卷12期864-9页

1696. Foot ulcers.

作者: B E Sumpio.
来源: N Engl J Med. 2000年343卷11期787-93页
The role of the primary care physician in the evaluation, diagnosis, and management of pedal wounds is critical (Table 2). Patient education is essential for the reduction of risk factors and for the early recognition of foot complications. Careful assessment of vascular disease (leading to bypass surgery when indicated), evaluation and management of biomechanical abnormalities, and aggressive treatment of any infections are also required. Optimal management can reduce the number of major amputations, prevent infection, decrease the probability of ulceration, maintain skin integrity, and improve function. The multidisciplinary approach will provide a comprehensive treatment protocol that will increase the long-term viability of the foot.

1697. The HLA system. Second of two parts.

作者: J Klein.;A Sato.
来源: N Engl J Med. 2000年343卷11期782-6页

1698. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

作者: C A Dinarello.
来源: N Engl J Med. 2000年343卷10期732-4页

1699. Treatment of acute ischemic stroke.

作者: T Brott.;J Bogousslavsky.
来源: N Engl J Med. 2000年343卷10期710-22页

1700. The HLA system. First of two parts.

作者: J Klein.;A Sato.
来源: N Engl J Med. 2000年343卷10期702-9页
共有 3920 条符合本次的查询结果, 用时 5.5844667 秒